D. Viza

1.0k total citations
62 papers, 694 citations indexed

About

D. Viza is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, D. Viza has authored 62 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 18 papers in Immunology and 12 papers in Oncology. Recurrent topics in D. Viza's work include Herpesvirus Infections and Treatments (11 papers), Cytomegalovirus and herpesvirus research (10 papers) and HIV Research and Treatment (9 papers). D. Viza is often cited by papers focused on Herpesvirus Infections and Treatments (11 papers), Cytomegalovirus and herpesvirus research (10 papers) and HIV Research and Treatment (9 papers). D. Viza collaborates with scholars based in France, Italy and United States. D. Viza's co-authors include Caterina De Vinci, D. A. L. Davies, John C. Phillips, G. Pizza, R Harris, J Dausset, Giancarlo Pizza, R M Binns, J Colombani and Aldopaolo Palareti and has published in prestigious journals such as Nature, The Lancet and Blood.

In The Last Decade

D. Viza

60 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Viza France 16 253 174 147 124 95 62 694
B. Wahren Sweden 10 291 1.2× 133 0.8× 118 0.8× 56 0.5× 90 0.9× 15 553
D. W. Wara United States 18 246 1.0× 403 2.3× 231 1.6× 59 0.5× 156 1.6× 27 1.0k
R C Burton United States 13 542 2.1× 227 1.3× 79 0.5× 150 1.2× 40 0.4× 27 821
Rajendra N. Pahwa United States 13 400 1.6× 157 0.9× 94 0.6× 90 0.7× 43 0.5× 20 718
Victoria Schauf United States 16 241 1.0× 360 2.1× 102 0.7× 77 0.6× 312 3.3× 38 895
Caterina De Vinci Italy 12 190 0.8× 101 0.6× 84 0.6× 117 0.9× 51 0.5× 27 446
Anthony J. Infante United States 16 408 1.6× 118 0.7× 178 1.2× 117 0.9× 83 0.9× 39 818
César Boggiano United States 14 736 2.9× 146 0.8× 199 1.4× 109 0.9× 82 0.9× 24 1.1k
Margaret Nelson Australia 25 604 2.4× 260 1.5× 300 2.0× 297 2.4× 198 2.1× 66 1.5k
E. Weinmann Germany 13 98 0.4× 192 1.1× 90 0.6× 50 0.4× 105 1.1× 30 513

Countries citing papers authored by D. Viza

Since Specialization
Citations

This map shows the geographic impact of D. Viza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Viza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Viza more than expected).

Fields of papers citing papers by D. Viza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Viza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Viza. The network helps show where D. Viza may publish in the future.

Co-authorship network of co-authors of D. Viza

This figure shows the co-authorship network connecting the top 25 collaborators of D. Viza. A scholar is included among the top collaborators of D. Viza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Viza. D. Viza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viza, D., et al.. (2020). Transfer Factor as an Option for Managing the COVID-19 Pandemic. Folia Biologica. 66(3). 86–90. 3 indexed citations
2.
Viza, D., et al.. (2013). Transfer Factor: an Overlooked Potential for the Prevention and Treatment of Infectious Diseases. Folia Biologica. 59(2). 53–67. 35 indexed citations
3.
Pizza, Giancarlo, et al.. (2006). Cell mediated immunity to meet the avian influenza A (H5N1) challenge. Medical Hypotheses. 67(3). 601–608. 6 indexed citations
4.
Pizza, G., Caterina De Vinci, & D. Viza. (2002). Immunotherapeutic Approaches for Renal Cancer. Folia Biologica. 48(5). 167–181. 7 indexed citations
5.
Vinci, Caterina De, et al.. (1996). Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): A preliminary report. Biotherapy. 9(1-3). 133–138. 4 indexed citations
6.
Raise, Enzo, et al.. (1996). Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and Zidovudine (ZDV). Biotherapy. 9(1-3). 49–54. 10 indexed citations
7.
Pizza, Giancarlo, et al.. (1996). In vitro studies during long term oral administration of specific transfer factor. Biotherapy. 9(1-3). 175–185. 10 indexed citations
8.
Pizza, Giancarlo, et al.. (1996). Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses. Biotherapy. 9(1-3). 67–72. 17 indexed citations
9.
Ablashi, Dharam V., Paul H. Levine, Caterina De Vinci, et al.. (1996). Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy. 9(1-3). 81–86. 3 indexed citations
10.
Campos, Emilio C., et al.. (1996). Efficacy of transfer factor in treating patients with recurrent ocular herpes infections. Biotherapy. 9(1-3). 61–66. 13 indexed citations
11.
Pizza, Giancarlo, et al.. (1996). A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy. 9(1-3). 123–132. 17 indexed citations
12.
Prasad, U., Pathmanathan Rajadurai, Giancarlo Pizza, et al.. (1996). Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: A pilot study. Biotherapy. 9(1-3). 109–115. 10 indexed citations
13.
Pizza, Giancarlo, et al.. (1994). Transfer factor prevents relapses in herpes keratitis patients: A pilot study. Biotherapy. 8(1). 63–68. 11 indexed citations
14.
Aranda‐Anzaldo, Armando & D. Viza. (1992). Human immunodeficiency virus type 1 productive infection in staurosporine‐blocked quiescent cells. FEBS Letters. 308(2). 170–174. 2 indexed citations
15.
Aranda‐Anzaldo, Armando, D. Viza, & R. G. Busnel. (1992). Chemical inactivation of human immunodeficiency virus in vitro. Journal of Virological Methods. 37(1). 71–81. 21 indexed citations
16.
Viza, D., et al.. (1991). Dimethyl Sulfoxide Inhibits Human Immunodeficiency Virus Production in vitro. Intervirology. 32(1). 59–64. 7 indexed citations
17.
Viza, D., et al.. (1988). Soluble extracts from a lymphoblastoid cell line modulate simian immunodeficiency syndrome (SAIDS) evolution. Journal of Virological Methods. 21(1-4). 241–253. 8 indexed citations
18.
Viza, D., et al.. (1987). Use of specific transfer factor for the prevention or the treatment of herpes infections in mice and in man.. PubMed. 3(4). 407–20. 6 indexed citations
19.
Harris, Robert J., et al.. (1972). Cell differentiation : the proceedings of the first International Conference on Cell Differentiation. Munksgaard eBooks. 1 indexed citations
20.
Viza, D.. (1972). Immunological aspects of human leukaemia.. PubMed. 5(5). 87–108. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026